Private equity's expanding presence in urgent care and the consolidation of the industry raise concerns about the quality and affordability of care, according to a recent report. It argued that the industry should be wary about this ownership trend, as private equity firms could cut staff, push costly procedures and strip out assets from providers.
While informed consent is a critical process for ensuring participant autonomy in clinical research, consent forms are too long, unclear, difficult to read, and frequently exceed 9th grade reading levels.
To tailor a patient-friendly informed consent experience that meets the unique learning needs of varying patient populations click here to learn how.
We personally invite you to join us at Pegasus Park in Dallas on Wednesday, September 28 to partake in thought provoking panel discussions. Plus, this event offers an 8:1 ratio of attendees to investors for those seeking funding and a desire to network.
Don't miss this valuable opportunity to save $100 with our Early Bird Rate (ends 8/26).
On the heels of receiving a landmark FDA approval in breast cancer, AstraZeneca and Daiichi Sankyo drug Enhertu won an additional approval in non-small cell lung cancer. The decision makes the drug the first targeted NSCLC therapy addressing the cancer protein HER2.
Replace the tedious manual resume screening process! Learn how AI frameworks and technology are streamlining the recruiter/candidate experience, resulting in healthcare industries hiring skilled and knowledgeable personnel quickly and effectively.
No comments